These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ. Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [Abstract] [Full Text] [Related]
3. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV, Welsh RM, Haspel MV. J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198 [Abstract] [Full Text] [Related]
4. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity. Gorelik E, Gunji Y, Herberman RB. J Immunol; 1988 Mar 15; 140(6):2096-102. PubMed ID: 3126240 [Abstract] [Full Text] [Related]
5. Role of lymphokine-activated killer cells as mediators of veto and natural suppression. Azuma E, Kaplan J. J Immunol; 1988 Oct 15; 141(8):2601-6. PubMed ID: 3171179 [Abstract] [Full Text] [Related]
6. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells. Lotzová E, Savary CA, Stringfellow DA. J Immunol; 1983 Feb 15; 130(2):965-9. PubMed ID: 6848603 [Abstract] [Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F, Peri G, Villa A, Mantovani A. J Immunol; 1984 Feb 15; 132(2):936-44. PubMed ID: 6690624 [Abstract] [Full Text] [Related]
8. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. Colmenares C, Lopez C. J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891 [Abstract] [Full Text] [Related]
10. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis. Sheil JM, Gallimore PH, Zimmer SG, Sopori ML. J Immunol; 1984 Mar 01; 132(3):1578-82. PubMed ID: 6319497 [Abstract] [Full Text] [Related]
11. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells. Johnson PW, Trimble WS, Hozumi N, Roder JC. J Immunol; 1987 Jun 01; 138(11):3996-4003. PubMed ID: 3495578 [Abstract] [Full Text] [Related]
14. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator. Kalland T, Alm G, Stålhandshe T. J Immunol; 1985 Jun 01; 134(6):3956-61. PubMed ID: 2580900 [Abstract] [Full Text] [Related]
20. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen. Brooks CG, Holscher M, Urdal D. J Immunol; 1985 Aug 01; 135(2):1145-52. PubMed ID: 2409140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]